loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Centhaquine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Centhaquine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmazz & Dr. Reddy's have entered into a lice agreement to market Centhaquine
    Pharmazz & Dr. Reddy's have entered into a lice agreement to market Centhaquine

    22 Mar 2024

    // PRESS RELEASE

    https://www.drreddys.com/cms/cms/sites/default/files/2024-03/Dr.%20Reddy%27s%20and%20Pharmazz%2C%20Inc.%20enter%20into%20licensing%20agreement%20to%20market%20first-in-class%20Centhaquine%20%28Lyfaquin%C2%AE%29%20for%20hypovolemic%20shock%20in%20India.pdf

    PRESS RELEASE
    22 Mar 2024
    Share Share
    Pharmazz Inc. Presents Data From its Positive Phase III Study of Centhaquine
    Pharmazz Inc. Presents Data From its Positive Phase III Study of Centhaquine

    13 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/13/2514839/0/en/Pharmazz-Inc-Presents-Data-From-its-Positive-Phase-III-Study-of-Centhaquine-PMZ-2010-as-a-Resuscitative-Agent-in-Hypovolemic-Shock-Patients-at-Upcoming-Military-Health-System-Resea.html

    GLOBENEWSWIRE
    13 Sep 2022
    Share Share
    Marketing authorization received for Lyfaquin™ (centhaquine)
    Marketing authorization received for Lyfaquin™ (centhaquine)

    14 May 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/marketing-authorization-received-for-lyfaquin-centhaquine-to-treat-patients-with-hypovolemic-shock-from-indian-regulatory-agency-301059610.html

    PRNEWSWIRE
    14 May 2020
    Share Share